| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1827145A Chinese medicinal composition with beautifying function and method for preparing the same |
| 09/06/2006 | CN1827144A Externally applied Chinese medicinal mixture for treating onychomycosis |
| 09/06/2006 | CN1827133A Medicine for treating dermatopathy and its preparing process |
| 09/06/2006 | CN1827124A Dripping pills of herba lamiophlomis rotatae and method for preparing the same |
| 09/06/2006 | CN1827084A Spot-removing skin-rehabilitating agent with gingseng, bamboo leaf and flavone for medical beautification |
| 09/06/2006 | CN1273466C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273185C Natural Chinese herb composition for treating alopecia and leucotrichia and its application |
| 09/06/2006 | CN1273163C Externally applied medicine for treating acute soft tissue injury |
| 09/06/2006 | CN1273141C Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate and preparation method thereof |
| 09/06/2006 | CN1273136C Compound chlorhexidine acetate cream |
| 09/06/2006 | CN1273121C Compounds for blocking androgen receptors |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/06/2006 | CN1273024C Medicine containing bamboo vinegar, chitosan and silver ion, and preparation method and application thereof |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101889 Lipase inhibiting composition |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101880 Peptidic compounds as cysteine protease inhibitors |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101865 24-sulfoximine vitamin D3 compounds |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101863 For skin, muscle, ocular or gastric mucosal healing |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101553 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/05/2006 | US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 09/05/2006 | US7101537 Sunscreen agents |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 08/31/2006 | WO2006091033A1 Composition for reducing the exudation of serum proteins |
| 08/31/2006 | WO2006090935A1 Acerola fruit-derived pectin and use thereof |
| 08/31/2006 | WO2006090850A1 Benzamide compound |
| 08/31/2006 | WO2006090830A1 Method of producing proanthocyanidin oligomer |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090613A1 Hair cosmetic |
| 08/31/2006 | WO2006090274A1 Crystalline acat inhibitor |
| 08/31/2006 | WO2006089881A1 Use of phenanthrene derivatives as anti-inflammatory agents, synthesis method and intermediate products |
| 08/31/2006 | WO2006089586A1 Use of a compound with clusterin activity for the treatment of diseases associated with the deposition of abnormal proteins |
| 08/31/2006 | WO2006061155A3 Stabilisation of glucocorticoid esters with acids |
| 08/31/2006 | WO2006060614A9 Methods for preparing pimecrolimus |
| 08/31/2006 | WO2006048747A8 Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound |
| 08/31/2006 | US20060194881 Composition comprising at least one alkanolamide to inhibit megration of langerhans cells and uses therof |
| 08/31/2006 | US20060194872 Diamine derivative, production process therefor and antioxidant |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194854 New 2-substituted - 1,3-thiazole compounds |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194836 Novel compounds having 4-pyridylalkylthio group as substituent |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060194292 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 08/31/2006 | US20060193929 Method for treating or preventing symptoms associated with menopause |
| 08/31/2006 | US20060193905 Direct cellular energy delivery system |
| 08/31/2006 | US20060193826 Methods to mobilize progenitor/stem cells |
| 08/31/2006 | DE202006009996U1 Oil ensemble, useful for the treatment of dry, badly strained and/or sore skin and skin affected by radiation, comprises an oil combination of a rapeseed oil, a thistle oil, a sesame (seed) oil and a vegetable-emulsifying agent |
| 08/31/2006 | DE202006003249U1 Preparation useful for treating wound, comprises natural complex of chitin, 1,3-beta-D-glucan, 1,6-beta-D-glucan and melanin that is produced from fungus of Fomes fomentarius, where component is used for powder basic substance |
| 08/31/2006 | DE102004060314A1 Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen Active ingredient combinations of one or more isoflavonoids and carnitine and / or one or more acyl-carnitines |
| 08/31/2006 | CA2599315A1 Composition for reducing the exudation of serum proteins |
| 08/31/2006 | CA2599295A1 Method of producing proanthocyanidin oligomer |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1695980A2 Human papillomavirus E2 transactivation domain / inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 08/30/2006 | EP1695974A1 1,8-Naphthyridines as CRF antagonists |
| 08/30/2006 | EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 08/30/2006 | EP1695959A1 Compouds and methods for the inhibition of the expression of VCAM-1 |
| 08/30/2006 | EP1695722A1 Collagen hemostatic foam |
| 08/30/2006 | EP1695708A2 Pharmaceutical composition |
| 08/30/2006 | EP1695707A1 Nail varnish containing tazarotene and use thereof for treating and/or preventing psoriasis |
| 08/30/2006 | EP1695691A2 Foaming composition for hair cleaning and hair treatment |
| 08/30/2006 | EP1694627A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 08/30/2006 | EP1694370A1 Wound care products containing keratin |
| 08/30/2006 | EP1694343A1 Compositions and methods for the treatment of skin damage |
| 08/30/2006 | EP1694324A2 Methods for reducing the effects of stress on skin condition |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1425280B1 Hetero-bicyclic crf antagonists |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1399128B1 Composition for the treatment of diseases which affect animals' hooves |
| 08/30/2006 | EP1385519B1 Compounds for treating inflammatory diseases |
| 08/30/2006 | EP1383772B1 Nitrogen-based camptothecin derivatives |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | EP1276459B1 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 08/30/2006 | EP1272183B1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 08/30/2006 | EP1180524B1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 08/30/2006 | EP0793489B9 Use of statin for the treatment of skin disorders |
| 08/30/2006 | CN1826336A Cyclohexanecarboxylic acid compound |
| 08/30/2006 | CN1826127A Use of a lupeol-rich extract to make a pharmaceutical or cosmetic composition for treating or preventing degeneration of dermal, cartilage and/or gingival connective tissue |
| 08/30/2006 | CN1826126A Plant extract with prebiotic activity |
| 08/30/2006 | CN1826106A Chromatosis remedies |